pubs.acs.org/joc
and is present in several pharmacologically active mono-
Rhodium-Catalyzed Synthesis of 3-Hydroxy-
β-lactams via Oxonium Ylide Generation:
Three-Component Reaction between Azetidine-2,
3-diones, Ethyl Diazoacetate, and Alcohols
bactams such as sulfacezin and related products3 and in
enzyme inhibitors such as tabtoxin and its analogues.4 In
addition, these compounds are precursors of therapeutically
important compounds.5
On the other hand, the chemistry of diazo compounds is a
prolific area and a wide variety of literature has been
reported.6 In this context, the chemistry of carbonyl, phos-
phorus, sulfur, and ammonium ylides has been widely em-
ployed in organic synthesis.7
Benito Alcaide,*,† Pedro Almendros,‡ Cristina Aragoncillo,†
Ricardo Callejo,† M. Pilar Ruiz,† and M. Rosario Torres§
†
´
´
Departamento de Quımica Organica I, Facultad de Quımica,
ꢀ
Universidad Complutense, 28040-Madrid, Spain, ‡Instituto de
Multicomponent reactions (MCR) are a straightforward
synthetic tool to obtain structural complexity from three or
more reactants in a single reaction process, with greater
efficiency and atom economy.8 Recently, Hu has described
a novel reaction involving the Rh(II)-catalyzed aldol-type
three-component reaction of methyl phenyldiazoacetate
with an alcohol and an aldehyde(imine) providing a synthetic
route to access highly substituted hydroxy(amino) acid
skeletons with several quaternary centers in a single step
(Scheme 1).9 Of particular interest was the reaction with
isatins as the carbonyl component.9d
´
Quımica Organica General, CSIC, Juan de la Cierva 3, 28006-
Madrid, Spain, and Laboratorio de Difraccion de Rayos X.
ꢀ
§
ꢀ
´
Facultad de Quımica, Universidad Complutense, 28040-
Madrid, Spain
Received September 11, 2009
Continuing with our work on the asymmetric synthesis of
nitrogenated compounds of biological interest,10 in this
contribution we report the synthesis of 3-substituted-3-hy-
droxy-β-lactams with two new adjacent stereogenic centers
in a single step via an efficient and stereoselective trapping of
oxonium ylide with azetidine-2,3-diones.
(6) (a) Zhang, Z.; Wang, J. Tetrahedron 2008, 64, 6577. (b) Wee, A. G. H.
Curr. Org. Synth. 2006, 3, 499.
3-Substituted-3-hydroxy-β-lactams, with two new adja-
cent stereogenic centers, have been prepared in a single
step by a rhodium-catalyzed, three-component reaction
between azetidine-2,3-diones, ethyl diazoacetate, and
alcohols. Good to moderate stereoselectivity was ob-
tained depending on the alcohol used. The stereochemis-
try of the new centers has been undoubtedly assigned by
single crystal X-ray diffraction.
(7) For carbonyl ylides, see: (a) Doyle, M. P.; Mckervey, M. A.; Ye, T.
Modern Catalytic Methods for Organic Synthesis with Diazo Compounds;
Wiley: New York, 1998. (b) Li, A. H.; Dai, L. X.; Aggarwal, V. K. Chem. Rev.
1997, 97, 2341. (c) Padwa, A.; Weingarten, M. D. Chem. Rev. 1996, 96, 223.
(d) Ye, T.; McKervey, M. A. Chem. Rev. 1994, 94, 1091. For phosphonium
ylides, see: (e) Aggarwal, V. K.; Fulton, J. R.; Sheldon, C. G.; Vicente, J. D. J. Am.
Chem. Soc. 2003, 125, 6034. (f) Maryanoff, B. E.; Retiz, A. B. Chem. Rev. 1989,
89, 863. For oxonium ylides, see: (g) Tester, R. W.; West, F. G. Tetrahedron Lett.
1998, 39, 4631. (h) West, F. G.; Eberlein, T. H.; Tester, R. W. J. Chem. Soc.,
Perkin Trans. 1 1993, 2857. (i) Pirrung, M. P.; Werner, J. A. J. Am. Chem. Soc.
1986, 108, 6060. (j) Padwa, A.; Hornbuckle, S. F.; Fryxell, G. E.; Stull, P. D.
J. Org. Chem. 1989, 54, 817. For ammonium ylides, see: (k) West, F. G.; Naidu,
B. N. J. Am. Chem. Soc. 1993, 115, 1177. (l) Doyle, M. P.; Bagheri, V.; Claxton,
E. E. J. Chem. Soc., Chem. Commun. 1990, 46. (m) Doyle, M. P.; Tamblyn, W.
H.; Bagheri, V. J. Org. Chem. 1981, 46, 5094.
The 3-substituted-3-hydroxy-β-lactam skeleton represents
an efficient carboxylate mimic,1 showing a promising acti-
vity in acyl CoA-cholesterol acyltransferase inhibition assays,2
ꢀ
(8) For reviews of multicomponent reaction, see: (a) Toure, B. B.; Hall,
D. G. Chem. Rev. 2009, 109, 4439. (b) Ganem, B. Acc. Chem. Res. 2009, 42,
ꢀ
463. (c) Guillena, G.; Ramon, D. J.; Yus, M. Tetrahedron: Asymmetry 2007,
18, 693. (d) Domling, A. Chem. Rev. 2006, 106, 17. (e) Nair, V.; Rajesh, C.;
€
Vinod, A. U.; Bindu, S.; Streekenth, A. R.; Balagopal, L. Acc. Chem. Res.
ꢀ
*To whom correspondence should be addressed.
2003, 36, 899. (f) Multicomponent Reactions: Zhu, J., Bienayme, H., Eds.;
(1) (a) Unkefer, C. J.; London, R. E.; Durbin, R. D.; Uchytil, T. F.;
Langston-Unkefer, P. J. J. Biol. Chem. 1987, 262, 4993. (b) Meek, T. D.;
Villafranca, J. V. Biochemistry 1980, 19, 5513. (c) Sinden, S. L.; Durbin, R. D.
Nature 1968, 219, 379.
(2) Benfatti, F.; Cardillo, G.; Gentilucci, L.; Perciccante, R.; Tolomelli,
A.; Catapano, A. J. Org. Chem. 2006, 71, 9229.
(3) Imada, A.; Gitano, K.; Kintana, K.; Muroi, M.; Asai, M. Nature
1981, 289, 590.
(4) (a) Dolle, R. E.; Hughes, M. J.; Li, C.-S.; Kruse, L. I. J. Chem. Soc.,
Chem. Commun. 1989, 1448. (b) Greenlee, W. J.; Springer, J. P.; Patchett,
A. A. J. Med. Chem. 1989, 32, 165. (c) Baldwin, J. E.; Otsuka, M.; Wallce,
P. M. Tetrahedron 1986, 42, 3097.
(5) As an example, (2R,3S)-3-amino-2-hydroxy-5-methylhexanoic acid
(norstatine) and (3R,4S)-4-amino-3-hydroxy-5-methylheptanoic acids (statine)
are residues for peptide inhibitors of enzymes such as rennin and HIV protease.
For rennin, see: Thaisrivongs, S.; Pals, D. T.; Kroll, L. T.; Turner, S. R.; Han,
F.-S. J. Med. Chem. 1987, 30, 976. For HIV protease, see: Huff, J. R. J. Med.
Chem. 1991, 34, 2305.
Wiley: Weinheim, Germany, 2005.
(9) (a) Zhu, Y.; Zhai, C.; Yue, Y.; Yang, L.; Hu, W. Chem. Commun.
2009, 1362. (b) Hu, W.; Xu, X.; Zhou, J.; Liu, W.-J.; Huang, H.; Hu, J.; Yang,
L.; Gong, L.-Z. J. Am. Chem. Soc. 2008, 130, 7782. (c) Huang, H.; Guo, X.;
Hu, W. Angew. Chem., Int. Ed. 2007, 46, 1337. (d) Guo, X.; Huang, H.; Yang,
L.; Hu, W. Org. Lett. 2007, 9, 4721. (e) Lu, C.; Liu, H.; Chen, Z.; Hu, W.; Mi,
A. Org. Lett. 2005, 7, 83. (f) Huang, H.; Wang, Y.; Chen, Z.; Hu, W. Adv.
Synth. Catal. 2005, 347, 531. (g) Wang, Y.; Chen, Z.; Mi, A.; Hu, W. Chem.
Commun. 2004, 2486. (h) Wang, Y.; Zhu, Y.; Chen, Z.; Mi, A.; Hu, W.;
Doyle, M. P. Org. Lett. 2003, 5, 3923.
(10) See, for instance: (a) Alcaide, B.; Almendros, P.; Martınez del
´
ꢀ
Campo, T.; Quiros, M. T. Chem.;Eur. J. 2009, 15, 3344. (b) Alcaide, B.;
Almendros, P.; Aragoncillo, C.; Cabrero, G.; Callejo, R.; Ruiz, M. P. Eur. J.
Org. Chem. 2008, 4434. (c) Alcaide, B.; Almendros, P.; Martı
T. Angew. Chem., Int. Ed. 2007, 46, 6684. (d) Alcaide, B.; Almendros, P.;
Martınez del Campo, T.; Rodrıguez-Acebes, R. Adv. Synth. Catal. 2007, 349,
´
nez del Campo,
´
´
749. (e) Alcaide, B.; Almendros, P.; Cabrero, G.; Ruiz, M. P. Chem.
Commun. 2007, 4788.
DOI: 10.1021/jo9019013
r
Published on Web 10/15/2009
J. Org. Chem. 2009, 74, 8421–8424 8421
2009 American Chemical Society